Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication - A 10-year follow-up of the Northern Finland 1966 Birth Cohort study

European Psychiatry

Volumn 28, Issue 1, 2013, Pages 53-58

  Moilanen, J ^a   Haapea, M ^a,b   Miettunen, J ^a,b   Jaaskelainen E ^a   Veijola, J ^a   Isohanni, M ^a   Koponen, H ^c  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antipsychotics; Medicated; Non medicated; Remission; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADULT; ARTICLE; BIRTH; COHORT ANALYSIS; DEMOGRAPHY; DISEASE DURATION; FAMILY HISTORY; FEMALE; FINLAND; FOLLOW UP; HOSPITALIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; REMISSION; SCHIZOPHRENIA; SCHIZOPHRENIA SPECTRUM DISORDER; SOCIOECONOMICS; ADOLESCENT; ALCOHOL USE DISORDER; DISABILITY; ONSET AGE; OUTPATIENT CARE; PENSION; POPULATION RESEARCH; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOPHARMACOTHERAPY; RELAPSE;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; FINLAND; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; PREVALENCE; RECURRENCE; SCHIZOPHRENIA; SEX FACTORS;

EID: 84872395809     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2011.06.009     Document Type: Article

References (23)

1. Almerie M., Matar H., Essali A., Alkhateeb H., Rezk E. Cessation of medication for people with schizophrenia already stable on chlorpromazine. Schizophr Bull. 2008, 34:13-14.
2. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: Proposed criteria and rationale for consensus. Am J Psychiatry. 2005, 162:441-449.
3. Brissos S., Dias V.V., Balanzá-Martinez V., Carita A.I., Figueira M.L. Symptomatic remission in schizophrenia patients: Relationship with social functioning, quality of life, and neurocognitive performance. Schizophr Res 2011, 10.1016/j.schres.2011.04.001.
4. Fenton W.S., McGlashan T.H. Sustained remission in drug-free schizophrenic patients. Am J Psych 1987, 144:1306-1309.
5. Gilbert P., Harris M., McAdams L., Jeste D. Neuroleptic withdrawal in schizophrenic patients. A review of the literature. Arch Gen Psychiatry. 1995, 52:173-188.
6. Guy W. EDCEU Assessment Manual for Psychopharmacology - Revised (DHEW Pupl No. ADM 76 338). Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976, p. 534-7.
7. Haapea M., Miettunen J., Veijola J., Lauronen E., Tanskanen P., Isohanni M. Non-participation may bias the results of a psychiatric survey: an analysis from the survey including magnetic resonance imaging within the Northern Finland 1966 Birth Cohort. Soc Psychiatry Psychiatric Epidemiol. 2007, 42:403-409.
8. Harrison G., Hopper K., Craig T., Laska E., Siegel C., Wanderling J., et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry 2001, 178:506-517.
9. Harrow M., Jobe T.H. Factors Involved in Outcome and Recovery in Schizophrenia Patients Not on Antipsychotic Medications: A 15-year multi-follow-up Study. J Nerv Ment Dis 2007, 195:406-414.
10. Hopper K, Harrison G, Wanderling JA. An overview of course and outcome in ISoS, in recovery from schizophrenia. An international perspective. In: Hopper K, HarrisonG, Janca A, Sartorius N (Eds). Oxford University Press, 2007, p. 23-38.
11. Isohanni M., Mäkikyrö T., Moring J., Räsänen P., Hakko H., Partanen U., et al. A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Soc Psychiatry Psychiatr Epidemiol. 1997, 32:303-308.
12. Kane J.M. Treatment strategies to prevent relapse and encourage remission. J Clin Psychiatry. 2007, 68:27-30.
13. Karow A., Moritz S., Lambert M., Schöttle D., Naber D. Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia. Eur Psychiatry 2011, on behalf of the EGOFORS initiative. 10.1016/j.eurpsy.2011.01.012.
14. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987, 13:261-276.
15. Leucht S., Komossa K., Rummel-Kluge C., Hunger H., Schmid F., Asenjo Lobos C., et al. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am J Psychiatry 2009, 166:152-163.
16. Maxwell ME. Family Interview for Genetic Studies (FIGS): manual for the FIGS. Clinical Neurogenetics Branch. Intramural Research Program, National Institute of Mental Health, Bethesda, MD; 1992.
17. Moilanen K., Veijola J., Läksy K., Mäkikyrö T., Miettunen J., Kantojärvi L., et al. Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort. Soc Psychiatry Psychiatric Epidemiol. 2003, 38:305-310.
18. Müller N. Mechanism of relapse prevention in schizophrenia. Pharmacopsychiatry. 2004, 37:141-147.
19. Nishikawa T., Hayashi T., Koga I., Uchida Y. Neuroleptic withdrawal with remitted schizophrenics: a naturalistic follow-up study. Psychiatry. 2007, 70:68-79.
20. Perälä J., Suvisaari J., Saarni S.I., Kuoppasalmi K., Isometsä E., Pirkola S., et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007, 64:19-28.
21. Rantakallio P. Groups at risk in low birth weight infants and perinatal mortality. Acta Paediatr Scand. 1969, 193:1-71.
22. Spitzer R.L., Gibbon M., Endicott J. Global Assessment Scale (GAS), Global Assesment of Functioning (GAF) scale, Social and Occupational Functional Assesment Scale (SOFAS). American Psychiatric Association. Handbook of Psychiatric Measures 2000, American Psychiatric Association, Washington.
23. Wunderink L., Nienhuis F.J., Sytema F., Slooff C.J., Knegtering R., Wiersma D. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: Relapse rates and functional outcome. J Clin Psychiatry 2007, 68:5.